{
    "medicine_id": "189aa5a178f31411404fda05cfda1588f39b5a86",
    "platform_id": "DB11596",
    "metadata": {
        "name": "Biopar delta FORTE 100 MG Injection powder for solution",
        "composition": "100 MG Levoleucovorin",
        "clinical_particulars": {
            "therapeutic_indications": "Levoleucovorin is indicated for use as rescue therapy following high dose methotrexate in the treatment of osteosarcoma or for diminishing the toxicity associated with inadvertent overdosage of folic acid antagonists Levoleucovorin as the product Fusilev FDA dosed at one half the usual dose of racemic d l leucovorin has an additional indication for use in combination chemotherapy with 5 fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer although they should not be mixed in the same infusion as a precipitate may form",
            "contraindications": {
                "disease": "Acute intravenous LD50 values in adult mice and rats were 575 mg kg 1725 mg m\u00b2 and 378 mg kg 2268 mg m\u00b2 respectively",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Levoleucovorin is actively and passively transported across cell membranes In vivo levoleucovorin is converted to 5 methyltetrahydrofolic acid 5 methyl THF the primary circulating form of active reduced folate Levoleucovorin and 5 methyl THF are polyglutamated intracellularly by the enzyme folylpolyglutamate synthetase Folylpolyglutamates are active and participate in biochemical pathways that require reduced folate",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB01320",
                        "description": "The serum concentration of Fosphenytoin can be decreased when it is combined with Levoleucovorin"
                    },
                    {
                        "drugbank-id": "DB00293",
                        "description": "The therapeutic efficacy of Raltitrexed can be decreased when used in combination with Levoleucovorin"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The serum concentration of Levoleucovorin can be decreased when it is combined with Sulfasalazine"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The serum concentration of Phenytoin can be decreased when it is combined with Levoleucovorin"
                    },
                    {
                        "drugbank-id": "DB08898",
                        "description": "The serum concentration of the active metabolites of Levoleucovorin can be reduced when Levoleucovorin is used in combination with Glucarpidase resulting in a loss in efficacy"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The serum concentration of Phenobarbital can be decreased when it is combined with Levoleucovorin"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The serum concentration of Primidone can be decreased when it is combined with Levoleucovorin"
                    },
                    {
                        "drugbank-id": "DB00205",
                        "description": "The therapeutic efficacy of Pyrimethamine can be decreased when used in combination with Levoleucovorin"
                    },
                    {
                        "drugbank-id": "DB00250",
                        "description": "The therapeutic efficacy of Dapsone can be decreased when used in combination with Levoleucovorin"
                    },
                    {
                        "drugbank-id": "DB00440",
                        "description": "The therapeutic efficacy of Trimethoprim can be decreased when used in combination with Levoleucovorin"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The therapeutic efficacy of Methotrexate can be decreased when used in combination with Levoleucovorin"
                    },
                    {
                        "drugbank-id": "DB00642",
                        "description": "The therapeutic efficacy of Pemetrexed can be decreased when used in combination with Levoleucovorin"
                    },
                    {
                        "drugbank-id": "DB01131",
                        "description": "The therapeutic efficacy of Proguanil can be decreased when used in combination with Levoleucovorin"
                    },
                    {
                        "drugbank-id": "DB01157",
                        "description": "The therapeutic efficacy of Trimetrexate can be decreased when used in combination with Levoleucovorin"
                    },
                    {
                        "drugbank-id": "DB03695",
                        "description": "The therapeutic efficacy of Piritrexim can be decreased when used in combination with Levoleucovorin"
                    },
                    {
                        "drugbank-id": "DB04655",
                        "description": "The therapeutic efficacy of Metoprine can be decreased when used in combination with Levoleucovorin"
                    },
                    {
                        "drugbank-id": "DB06358",
                        "description": "The therapeutic efficacy of Iclaprim can be decreased when used in combination with Levoleucovorin"
                    },
                    {
                        "drugbank-id": "DB06813",
                        "description": "The therapeutic efficacy of Pralatrexate can be decreased when used in combination with Levoleucovorin"
                    },
                    {
                        "drugbank-id": "DB08878",
                        "description": "The therapeutic efficacy of Aminopterin can be decreased when used in combination with Levoleucovorin"
                    },
                    {
                        "drugbank-id": "DB12769",
                        "description": "The therapeutic efficacy of Lometrexol can be decreased when used in combination with Levoleucovorin"
                    },
                    {
                        "drugbank-id": "DB12912",
                        "description": "The therapeutic efficacy of Nolatrexed can be decreased when used in combination with Levoleucovorin"
                    },
                    {
                        "drugbank-id": "DB13795",
                        "description": "The therapeutic efficacy of Brodimoprim can be decreased when used in combination with Levoleucovorin"
                    },
                    {
                        "drugbank-id": "DB14763",
                        "description": "The therapeutic efficacy of Cycloguanil can be decreased when used in combination with Levoleucovorin"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The serum concentration of Levoleucovorin can be decreased when it is combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00375",
                        "description": "The serum concentration of Levoleucovorin can be decreased when it is combined with Colestipol"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The serum concentration of Carbamazepine can be decreased when it is combined with Levoleucovorin"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of adverse effects can be increased when Levoleucovorin is combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB01099",
                        "description": "The risk or severity of adverse effects can be increased when Levoleucovorin is combined with Flucytosine"
                    },
                    {
                        "drugbank-id": "DB01101",
                        "description": "The risk or severity of adverse effects can be increased when Levoleucovorin is combined with Capecitabine"
                    },
                    {
                        "drugbank-id": "DB01629",
                        "description": "The risk or severity of adverse effects can be increased when Levoleucovorin is combined with 5 fluorouridine"
                    },
                    {
                        "drugbank-id": "DB03419",
                        "description": "The risk or severity of adverse effects can be increased when Levoleucovorin is combined with Uracil"
                    },
                    {
                        "drugbank-id": "DB09256",
                        "description": "The risk or severity of adverse effects can be increased when Levoleucovorin is combined with Tegafur"
                    },
                    {
                        "drugbank-id": "DB12947",
                        "description": "The risk or severity of adverse effects can be increased when Levoleucovorin is combined with Doxifluridine"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}